ImportRefusal LogoImportRefusal

Abbott Biologicals BV

⚠️ High Risk

FEI: 3000268812 • Olst, Overijssel • NETHERLANDS

FEI

FEI Number

3000268812

📍

Location

Olst, Overijssel

🇳🇱
🏢

Address

Veerweg 12, , Olst, Overijssel, Netherlands

High Risk

FDA Import Risk Assessment

64.3
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

7
Total Refusals
3
Unique Violations
12/19/2025
Latest Refusal
9/29/2011
Earliest Refusal

Score Breakdown

Violation Severity
85.0×40%
Refusal Volume
33.5×30%
Recency
98.7×20%
Frequency
4.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

756×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

711×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

Refusal History

DateProductViolationsDivision
12/19/2025
64GDY07ESTRADIOL (ESTROGEN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/26/2025
64GCA07ESTRADIOL (ESTROGEN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/1/2025
64GDY99ESTROGEN N.E.C.
118NOT LISTED
75UNAPPROVED
Division of Southeast Imports (DSEI)
3/29/2024
65JCA10DYDROGESTERONE (PROGESTIN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/4/2020
57CH02INFLUENZA VIRUS VACCINE
71NO LICENSE
Division of Southeast Imports (DSEI)
7/31/2019
65JCA10DYDROGESTERONE (PROGESTIN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
9/29/2011
66CCL99STOOL SOFTENER N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)

Frequently Asked Questions

What is Abbott Biologicals BV's FDA import refusal history?

Abbott Biologicals BV (FEI: 3000268812) has 7 FDA import refusal record(s) in our database, spanning from 9/29/2011 to 12/19/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Abbott Biologicals BV's FEI number is 3000268812.

What types of violations has Abbott Biologicals BV received?

Abbott Biologicals BV has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Abbott Biologicals BV come from?

All FDA import refusal data for Abbott Biologicals BV is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.